Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cronos Group (CRON)
NASDAQ:CRON
Cronos Group (CRON) Stock Price & Analysis
5,154 Followers
CRON Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.64 - $3.14
Previous Close$2.59
Volume1.44M
Average Volume (3M)3.40M
Market Cap
$990.53M
Enterprise Value$134.10M
Total Cash (Recent Filing)$855.11M
Total Debt (Recent Filing)$2.26M
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Aug 08, 2024EPS Estimate
>-$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding381,298,853
10 Day Avg. Volume1,835,915
30 Day Avg. Volume3,403,461
Standard Deviation0.16
R-Squared0.14
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.94
Price to Sales (P/S)42.45
Price to Cash Flow (P/CF)-113.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.94
Enterprise Value/Gross Profit11.26
Enterprise Value/Ebitda-32.24
Forecast
1Y Price Target
$2.76Price Target Upside6.56% Upside
Rating ConsensusHold
Number of Analyst Covering5
Cronos Group News
PremiumCompany Announcements
Cronos Group Reassesses Strategy After Deal Falls Through
Bulls Say, Bears Say
Bulls Say
Market ExpansionCannabis stocks rally on growing optimism for reform, with anticipated rule changes in Germany and Israel expected to boost medical cannabis sales.
Product SuccessCronos' introduction of new value-add products under the Spinach brand has marked a notable success in the market.
Strategic MergersThe potential merger with another cannabis company could lead to significant upside for Cronos shareholders if the transaction is settled via stock.
Bears Say
Financial PerformanceCronos' financial delivery has done little to support confidence in long-term value creation, with trends in 4Q23 showing gross margins dropping and high selling, general, and administrative expenses.
Geopolitical ImpactIncreased competition and conflict in Israel led to a 4Q gross margin miss, prompting analysts to cut sales forecasts, which could negatively impact the stock.
Legislative UncertaintyAnalyst remains cautious on US reform, as an election year normally adds to the gridlock in Congress, potentially stalling progress in the cannabis industry and affecting the stock.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was $1.64 and its highest was $3.14 in the past 12 months.
What is Cronos Group’s market cap?
Currently, no data Available
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is Aug 08, 2024 which is in 66 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on May 09, 2024. The company reported -$0.01 earnings per share for the quarter, the consensus estimate of -$0.01 by $0.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is >-$0.01.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,011,170 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of -$0.01 in its last earnings report, expectations of -$0.01. Following the earnings report the stock price went up 10.465%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in CRON
---
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$2.76 (6.56% Upside)
$2.76 (6.56% Upside)
Blogger Sentiment
Bullish
CRON Sentiment 78%
Sector Average 69%
Sector Average 69%
Crowd Wisdom
Positive
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
48.00%
12-Months-Change
Fundamentals
Return on Equity
-4.91%
Trailing 12-Months
Asset Growth
-4.40%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group, Inc. engages in the production and sale of cannabis in federally legal jurisdictions, including Canada and Germany. Its portfolio includes Peace Naturals, Original BC (OGBC) and Whistler Medical Marijuana Company (WMMC). The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.
---
CRON Earnings Call
Q1 2024
0:00 / 0:00
---
CRON Stock 12 Month Forecast
Average Price Target
$2.76
▲(6.56% Upside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
12/20 ratings generated profit
1 Year Average Return
+14.16%
reiterated a buy rating 24 days ago
Copying Matt Bottomley's trades and holding each position for 1 Year would result in 60.00% of your transactions generating a profit, with an average return of +14.16% per trade.
---